Literature DB >> 26209042

Intraductal Radiofrequency Ablation (RFA) for Pancreatic Cancer: Getting in Under the Wire?

Brian C Brauer1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26209042     DOI： 10.1007/s10620-015-3811-9

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  10 in total

1.  Endoscopically applied radiofrequency ablation appears to be safe in the treatment of malignant biliary obstruction.

Authors:  Alan W Steel; Aymer J Postgate; Shirin Khorsandi; Joanna Nicholls; Long Jiao; Pangiotis Vlavianos; Nagy Habib; David Westaby
Journal:  Gastrointest Endosc       Date:  2011-01       Impact factor: 9.427

2.  Analysis of Endoscopic Radiofrequency Ablation of Biliary Malignant Strictures in Pancreatic Cancer Suggests Potential Survival Benefit.

Authors:  Yiannis Kallis; Natalie Phillips; Alan Steel; Harry Kaltsidis; Panagiotis Vlavianos; Nagy Habib; David Westaby
Journal:  Dig Dis Sci       Date:  2015-06-03       Impact factor: 3.199

Review 3.  Outcomes in biliary malignancy.

Authors:  Bas Groot Koerkamp; Yuman Fong
Journal:  J Surg Oncol       Date:  2014-10       Impact factor: 3.454

4.  Activation and dramatically increased cytolytic activity of tumor specific T lymphocytes after radio-frequency ablation in patients with hepatocellular carcinoma and colorectal liver metastases.

Authors:  Johannes Hansler; Thaddaus-Till Wissniowski; Detlef Schuppan; Astrid Witte; Thomas Bernatik; Eckhart-Georg Hahn; Deike Strobel
Journal:  World J Gastroenterol       Date:  2006-06-21       Impact factor: 5.742

5.  Comparison of metal stenting with radiofrequency ablation versus stenting alone for treating malignant biliary strictures: is there an added benefit?

Authors:  Reem Z Sharaiha; Nikola Natov; Kati S Glockenberg; Jessica Widmer; Monica Gaidhane; Michel Kahaleh
Journal:  Dig Dis Sci       Date:  2014-07-18       Impact factor: 3.199

6.  In situ tumor ablation creates an antigen source for the generation of antitumor immunity.

Authors:  Martijn H M G M den Brok; Roger P M Sutmuller; Robbert van der Voort; Erik J Bennink; Carl G Figdor; Theo J M Ruers; Gosse J Adema
Journal:  Cancer Res       Date:  2004-06-01       Impact factor: 12.701

7.  Validation of the 6th edition AJCC Pancreatic Cancer Staging System: report from the National Cancer Database.

Authors:  Karl Y Bilimoria; David J Bentrem; Clifford Y Ko; Jamie Ritchey; Andrew K Stewart; David P Winchester; Mark S Talamonti
Journal:  Cancer       Date:  2007-08-15       Impact factor: 6.860

8.  SBRT in unresectable advanced pancreatic cancer: preliminary results of a mono-institutional experience.

Authors:  Angelo Tozzi; Tiziana Comito; Filippo Alongi; Pierina Navarria; Cristina Iftode; Pietro Mancosu; Giacomo Reggiori; Elena Clerici; Lorenza Rimassa; Alessandro Zerbi; Antonella Fogliata; Luca Cozzi; Stefano Tomatis; Marta Scorsetti
Journal:  Radiat Oncol       Date:  2013-06-21       Impact factor: 3.481

9.  Safety and efficacy of radiofrequency ablation in the management of unresectable bile duct and pancreatic cancer: a novel palliation technique.

Authors:  Paola Figueroa-Barojas; Mihir R Bakhru; Nagy A Habib; Kristi Ellen; Jennifer Millman; Armeen Jamal-Kabani; Monica Gaidhane; Michel Kahaleh
Journal:  J Oncol       Date:  2013-04-08       Impact factor: 4.375

Review 10.  Systemic treatment for inoperable pancreatic adenocarcinoma: review and update.

Authors:  Stephen L Chan; Sin T Chan; Eric H Chan; Zhe-Xi He
Journal:  Chin J Cancer       Date:  2014-01-29
  10 in total
  1 in total

1.  Radiofrequency assisted pancreaticoduodenectomy for palliative surgical resection of locally advanced pancreatic adenocarcinoma.

Authors:  Jayant Kumar; Isabella Reccia; Mikael H Sodergren; Tomokazu Kusano; Artur Zanellato; Madhava Pai; Duncan Spalding; Dimitris Zacharoulis; Nagy Habib
Journal:  Oncotarget       Date:  2018-02-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.